According to all the good news about the COVID-19 vaccine from BioNTech, the share price of the Mainz-based company is…
Read More »Vaccine
After the US approval, BioNTech and its partner Pfizer have received the emergency approval in the European Union for their…
Read More »On the NASDAQ, the BioNTech share wobbled vigorously yesterday, but did not fall and again it was the area around…
Read More »Update 12:55 p.m.: According to the AFP news agency, approval of the vaccine before Christmas in Europe is anything but…
Read More »The company, based in northern Luxembourg, has seen its order book swell visibly in recent weeks. It is true that…
Read More »After the decisions at the most recent crucial meeting of the responsible Fed committee, it was actually just a mere…
Read More »The first corona vaccinations in the UK with the vaccine from BioNTech and Pfizer saw violent reactions from two people…
Read More »The first hurdle is over: In trading on the BioNTech share, the BioNTech share managed yesterday to jump over smaller…
Read More »Medigene has received further results from the clinical phase I / II study with the company’s dendritic cell vaccine in…
Read More »Not only gold, silver has also gone down in price. But things could soon go up again. Unlike gold, silver…
Read More »